 |
TEXTBOOK AND PUBLICATION ERRATA
Correction Notice: Ertapenem information in Handbook on Injectable Drugs,
14th Edition
(2/13/2007)
Handbook on Injectable Drugs, 14th Edition
Ertapenem Monograph
Y-Site Injection Compatibility Table, page 633 and
Cross-reference to Ertapenem, page 855
The publishers of the Handbook on Injectable Drugs (HID), 14th edition, wish to inform you of a typographical error in the monograph for Ertapenem. In the third column from the left on page 633 of the printed volume of HID 14th ed. under the “Heparin sodium” entry of the table, the concentration should be listed as “40 and 100 units/mL” and “50 and 100 units/mL.”
Drug |
Mfr |
Conc |
Mfr |
Conc |
Remarks |
Ref |
C/I |
Heparin sodium |
APP |
40 and 100 units/mLa |
ME |
10 mg/mLb |
Visually compatible with about 4% ertapenem loss by HPLC in 4 hr |
2487 |
C |
|
APP |
50 and 100 units/mLb |
ME |
10 mg/mLb |
Visually compatible with about 3% ertapenem loss by HPLC in 4 hr |
2487 |
C |
a Tested in dextrose 5%.
b Tested in sodium chloride 0.9%
The error is carried over to the cross-reference. In the fifth column from the left on page 855 of the printed volume of HID 14th ed. under the Ertapenem entry of the table, the concentration should be listed as “40 and 100 units/mL” and “50 and 100 units/mL.”
Drug |
Mfr |
Conc |
Mfr |
Conc |
Remarks |
Ref |
C/I |
Ertapenem |
ME |
10 mg/mLb |
APP |
40 and 100 units/mLa |
Visually compatible with about 4% ertapenem loss by HPLC in 4 hr |
2487 |
C |
|
ME |
10 mg/mLb |
APP |
50 and 100 units/mLb |
Visually compatible with about 3% ertapenem loss by HPLC in 4 hr |
2487 |
C |
aTested in dextrose 5%.
bTested in sodium chloride 0.9%.
We urge you to correct this error in all copies of HID 14th ed. immediately and to communicate it to others on your staff who may use the book.
|
200 Lakeside Drive, Suite 200, Horsham, PA 19044,
Phone: (215) 947-7797, Fax: (215) 914-1492
© 2012 Institute for Safe Medication Practices. All rights reserved
|
|
|
 |